{"title":"Synthesis of novel piperazine-based bis(thiazole)(1,3,4-thiadiazole) hybrids as anti-cancer agents through caspase-dependent apoptosis","link":"http://pubs.rsc.org/en/Content/ArticleLanding/2024/RA/D4RA05091F","date":null,"content":"<div><p><img src=\"/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D4RA05091F\" /></p></div><div><i><b>RSC Adv.</b></i>, 2024, <b>14</b>,24992-25006<br /><b>DOI</b>: 10.1039/D4RA05091F, Paper</div><div><img alt=\"Open Access\" src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png\" /> Open Access</div><div><a href=\"http://creativecommons.org/licenses/by-nc/3.0/\" target=\"_blank\"> <img src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY-NC.png\" alt=\"Creative Commons Licence\" /></a>Â  This article is licensed under a <a href=\"http://creativecommons.org/licenses/by-nc/3.0/\" target=\"_blank\">Creative Commons Attribution-NonCommercial 3.0 Unported Licence.</a></div><div>Doaa M. Mohamed, Nabila A. Kheder, Marwa Sharaky, Mohamed S. Nafie, Kamal M. Dawood, Ashraf A. Abbas<br />Compound <strong>9i</strong> as a novel piperazine-based bis(thiazoles) and bis(thiadiazole) derivative was synthesized and characterized as potent EGFR inhibitor with promising cytotoxicity against HCT-116 cells through apoptosis.<br />The content of this RSS Feed (c) The Royal Society of Chemistry</div>","author":"","siteTitle":"RSC - RSC Adv. latest articles","siteHash":"da3e282678330308414c63a405ade89dd3738fcce2936ca8a2fe3a6d7e967d99","entryHash":"b67036b0f4a98f8529a1b34f2e55572aeabf46b7e57e642bbe565ebeaa1718e7","category":"Environment"}